Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, CHI, PER

Stanford Medicine Children's Health Welcomes New Chief of the Division of Abdominal Transplantation


PALO ALTO, Calif., April 24, 2024 /PRNewswire/ -- Marc Melcher, MD, has been appointed the new Chief of the Division of Abdominal Transplantation at Stanford Medicine. In his new role, he oversees all aspects of abdominal transplant programs, including liver, kidney, and small bowel transplantation at Stanford Medicine Children's Health.

"As one of the largest and most experienced pediatric transplant programs in the country, we see some of the most complex patients needing all kinds of transplants and presenting with the toughest challenges. I am honored to continue the growth of the program to provide comprehensive, patient-centered care to those who are waiting for a lifesaving transplant," Dr. Melcher says.

Dr. Melcher follows Carlos O. Esquivel, MD, who has been Division Chief since 1998. Dr. Esquivel was an early advocate for offering liver transplants to sick babies and children. Dr. Esquivel will continue his work treating patients at Stanford Children's.

In line with the mission of the Pediatric Transplant Center, Dr. Melcher's clinical and research efforts are focused on increasing the number of patients whose lives can be saved with transplantation. One of those focuses will be on expanding the living donor program, as it not only increases the organ pool, but has the added benefit of reducing wait times for transplant, significantly improving outcomes for pediatric patients. He is also exploring how AI algorithms can help make decisions in transplantation surgery.

In addition, Dr. Melcher is a professor of surgery at the Stanford School of Medicine and the current Abdominal Transplant Fellowship Director. After completing his medical doctorate at Columbia University and a PhD in molecular biology at UC Berkeley, he did his residency at Stanford University and fellowship at the University of California, San Francisco.

Media Contact
Katie Chen
[email protected]
(650) 465-4872

About Stanford Medicine Children's Health

Stanford Medicine Children's Health, with Lucile Packard Children's Hospital Stanford at its center, is the Bay Area's largest health care system exclusively dedicated to children and expectant mothers. Our network of care includes more than 65 locations across Northern California and more than 85 locations in the U.S. Western region. Along with Stanford Health Care and the Stanford School of Medicine, we are part of Stanford Medicine, an ecosystem harnessing the potential of biomedicine through collaborative research, education, and clinical care to improve health outcomes around the world. We are a nonprofit organization committed to supporting the community through meaningful outreach programs and services and providing necessary medical care to families, regardless of their ability to pay. Discover more at stanfordchildrens.org.

SOURCE Stanford Medicine Children's Health and Lucile Packard Children's Hospital Stanford


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: